biomedicina slovenica


re="CANCER" : 807

  1. Sedlar Aleš; Kranjc Simona; Dolinšek Tanja; Čemažar Maja; Coer Andrej; Serša Gregor
    Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma
    2012
  2. Ocana Alberto; Vera-Badillo Francisco; Šeruga Boštjan; Templeton Arnoud; Pandiella Atanasio; Amir Etian
    HER3 overexpression and survival in solid tumors: a meta-analysis
    2013
  3. Kesić Vesna; Poljak Mario; Rogovskaya Svetlana
    Cervical cancer burden and prevention activities in Europe
    2012
  4. Tajnik Mojca; Stražišar Mojca; Volavšek Metka; Boštjančič Emanuela; Glavač Damjan
    BBC3 is down-regulated with increased tumor size independently of p53 expression in head and neck cancer
    2012
  5. Templeton Arnoud; Ocaña Alberto; Šeruga Boštjan; Vera-Badillo Francisco; Carlsson Lindsay; Bedard Philippe L.; Amir Eitan
    Management of small HER2 overexpressing tumours
    2012
  6. Vardy JL; Pond Gregory Russell; Dodd Anna; Warr David; Šeruga Boštjan; Clemons Mark J; Bordeleau Louise; Goodwin Peter C; Tannock Ian
    A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer
    2012
  7. Amir Eitan; Bedard Philippe L.; Ocaña Alberto; Šeruga Boštjan
    Benefits and harms of detecting clinically occult breast cancer
    2012
  8. Ocaña Alberto; Amir Eitan; Šeruga Boštjan; Martin Miguel; Pandiella Atanasio
    The evolving landscape of protein kinases in breast cancer: clinical implications
    2013
  9. Merlo Domenico Franco; Primic-Žakelj Maja
    Breast cancer incidence trends in European women aged 20-39 years at diagnosis
    2012
  10. Lukanovič Adolf
    Long term consequences of cervical cancer treatment
    2012
  11. Kocjan Boštjan J; Seme Katja; Cimerman Mojca; Kovanda A; Potočnik Marko; Poljak Mario
    Genomic diversity of human papillomavirus (HPV) genotype 38
    2008
  12. Kocjan Boštjan J; Poljak Mario; Seme katja; Fujs Kristina; Potočnik Marko
    Distribution of human papillomavirus genotypes in Slovenian patients wirh common cutaneous warts
    2004
  13. Kocjan BJ; Seme K; Poljak M
    Evaluation of the abbott realtime high risk HPV test for the detection and identification of human papillomaviruses in archival cervical cancer speciments
    2011
  14. Jentschke Matthias; Soergel Philipp; Lange Victoria; Kocjan Boštjan; Doerk Thilo; Luyten Alexander; Petry Karl Urlich; Poljak Mario; Hillemanns Peter
    Evaluation of a new multiplex real-time polymerase chain reaction assay for the detection of human papillomavirus infections in a referral population
    2012
  15. Siesling Sabine; Primic-Žakelj Maja
    Rare thoracic cancers, including peritoneum mesothelioma
    2012
  16. Sodja Eva; Knez Lea; Kern Izidor; Ovčariček Tanja; Sadikov Aleksander; Čufer Tanja
    Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy
    2012
  17. Poljšak Borut; Glavan Uroš; Dahmane Raja
    Skin cancer, free radicals and antioxidants
    2011
  18. Uršič-Vrščaj Marjetka; Poljak Mario
    Use of high-risk human papilloma virus testing in cervical cancer control
    2012
  19. Kocjan Boštjan J; Poljak Mario
    Human papillomaviruses in cervical carcinogenesis
    2012
  20. Erčulj Nina; Faganel-Kotnik Barbara; Debeljak Maruša; Jazbec Janez; Dolžan Vita
    DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia
    2012
  21. Plesničar Andrej; Urbančič Klaudia; Mlinar Suzana; Kralj Božo; Kovač Viljem; Kores-Plesničar Blanka
    Early detection and prevention of breast cancer: the increasing importance of midwives in the future
    2012
  22. Ocvirk Janja; Boc Marko; Mesti Tanja
    Long-term survival of a patient with mCRC treated with ERBITUX and chemotherapy
    2012
  23. Reberšek Martina; Boc Marko
    A case of long-term survival in mCRC patient with adenocarcinoma of the sigmoid colon after curative liver surgery (followed by neoadjuvant treatment with ERBITUX plus chemotherapy) and maintenace with ERBITUX
    2012
  24. Ocvirk Janja; Boc Marko
    Long-term survival of a patient with mCRC treated with ERBITUX and chemotherapy followed by ERBITUX maintenance
    2012
  25. Knez L; Košnik M; Ovčariček T; Sadikov A; Sodja E; Kern I; Čufer T
    Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy
    2012
  26. Černe Jasmina Živa; Stegel Vida; Geršak Ksenija; Novaković Srdjan
    KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study
    2012
  27. Gatta Gemma; Primic-Žakelj Maja
    Rare cancers are not so rare: the rare cancer burden in Europe
    2011
  28. Trama A; Mallone S; Nicolai N; Necchi A; Schaapveld M; Gietema J; Znaor A; Ardanz E; Berrino F; Primic-Žakelj Maja
    Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
    2012
  29. Perše Martina
    Physical activity, dietary fat and colorectal cancer
    2012
  30. Perše M; Injac R; Štrukelj B; Cerar A
    High fat mixed lipid diet modifies protective effects of exercise on 1,2 dimethylhydrazine induced colon cancer in rats
    2012
  31. Sorbe B; Nordstrom B; Maenpaa J; Kuhelj J; Kuhelj D; Okkan S; Delaloye JF; Frankendal B
    Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study
    2009
  32. Prijič Sara; Prosen Lara; Čemažar Maja; Žnidaršič Andrej; Serša Gregor
    Magnetofection of reporter and therapeutic genes into different cell lines
    2011
  33. von Minckwitz Gunter; Schwedler Kathrin; Schmidt Marcus; Čufer Tanja
    Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer
    2011
  34. Regan MM; Price KN; Giobbie-Hurder A; Thuerliman B; Gelber RD; Čufer T; Pajk B; Červek J
    Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
    2011
  35. Trobec Katja; Knez Lea; Meško-Brguljan Pika; Čufer Tanja; Lainščak Mitja
    Estimation of renal function in lung cancer patients
    2012
  36. Serša Gregor; Čufer Tanja; Paulin-Košir Marija Snežna; Čemažar Maja; Snoj Marko
    Electrochemotherapy of chest wall breast cancer recurrence
    2011
  37. Amir Eitan; Šeruga Boštjan; Niraula Saroj; Carlsson Lindsay; Ocaña Alberto
    Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis
    2011
  38. Amir Eitan; Šeruga Boštjan; Kwong Ryan; Tannock Ian; Ocaña Alberto
    Poor correlation between progression-free and overall survival in modern clinical trials: are composite endpoints the answer?
    2012
  39. Kobal B; Cvjetičanin B; Meglič L; Smrkolj Š; Vakselj A; Barbič M
    Treatment outcome in patients with not optimal resectable peritoneal form of stage III ovarian cancer
    2011
  40. Smrkolj Š; Rakar S
    The clinical outcome of patients with figo stage IA2 squamous cell carcinoma of the uterine cervix
    2011
  41. Jabrane-Ferrat N; Campbell MJ; Esserman LJ; Peterlin BM
    Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice
    2006
  42. Van Dijk BAC; Gatta Gemma; Capocaccia R; Pierannunzio Daniela; Strojan Primož; Licitra Lisa
    Rare cancers of the head and neck area in Europe
    2012
  43. Černe Jasmina-Živa; Geršak Ksenija; Novaković Srdjan
    The influence of the genetic variant within miRNA-binding site in estrogen receptor alpha gene on the risk of breast cancer in postmenopausal women on hormone replacement therapy
    2011
  44. Pakiž Maja; Potočnik Uroš; But Igor; Mujezinović Faris
    A CYP17A1 gene polymorphism in association with multiple uterine leimyomas; a meta-analysis
    2011
  45. Perić Barbara; Žagar Ivana; Novaković Srdjan; Žgajnar Janez; Hočevar Marko
    Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma
    2011
  46. Edhemović Ibrahim; Gadžijev Eldar; Brecelj Erik; Miklavčič Damijan; Kos Bor; Županič Anže; Mali Barbara; Jarm Tomaž; Pavliha Denis; Marčan Marija; Gašljević Gorana; Gorjup Vesna; Marolt-Mušič Maja; Pečnik-Vavpotič Tjaša; Čemažar Maja; Snoj Marko; Serša Gregor
    Electrochemotherapy: a new technological approach in treatment of metastases in the liver
    2011
  47. Hu-Lieskovan Siwen; Bračko Matej; Velenik Vaneja
    EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients
    2011
  48. Bosetti Cristina; Pompe-Kirn Vera
    High constant incidence rates of second primary cancers of the head and neck: #a #pooled analysis of 13 cancer registries
    2011
  49. Hmeljak Julija; Erčulj Nina; Dolžan Vita; Kern Izidor; Coer Andrej
    BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients
    2011
  50. Rotar-Pavlič D; Visentin D; Peris D
    European forum for primary care - workshop primary care teams are important part of the chain
    2011
  51. Knez Lea; Sodja Eva; Kern Izidor; Košnik Mitja; Čufer Tanja
    Predictive value of multidrug resistance proteins, topoisomerases II and ERCC1 in small cell lung cancer: a systematic review
    2011
  52. Bränström Richard; Hočevar Marko; Perić Barbara
    Predictors of sun protection behaviors and severe sunburn in an international online study
    2010
  53. Kloboves-Prevodnik Veronika; Lavrenčak Jaka; Horvat Mateja; Jezeršek Novaković Barbara
    The predictive significance of CD20 expression in B-cell lymphomas
    2011
  54. Bränström Richard; Hočevar Marko; Perić Barbara
    Melanoma risk factors, perceived threat and intentional tanning: an international online survey
    2010
  55. Glavač Damjan
    MicroRNAs in skin morphogenesis and diseases
    2011
  56. Rosso Stefano; Primic-Žakelj Maja; Žagar Tina
    Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States
    2010
  57. Amir Eitan; Šeruga Boštjan; Serrano Rosario; Ocaña Alberto
    Targeting DNA repair in breast cancer: a clinical and translational update
    2010
  58. Matos Erika; Škrbinc Breda; Zakotnik Branko
    Fertility in patients treated for testicular cancer
    2010
  59. Čufer Tanja; Vrdoljak Eduard; Gaafar Rabab; Erensoy Inci; Pomberton Kristine
    Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (Iressa) of docetaxel as second-line theapy in patients with advanced (stage IIIB of IV) non-small-cell lung cancer
    2010
  60. Čufer Tanja
    Barriers and challenges for academic cancer research
    2010
  61. Čufer Tanja
    Translation research on new molecular markers: an EORTC BCG experinece
    2010
  62. Vogelsang M; Komel R
    Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch syndrome: a functional analysis report
    2011
  63. Amir Eitan; Freedman Orit C; Šeruga Boštjan; Evans Gareth D
    Assessing women at high risk of breast cancer ea review of risk assessment models
    2010
  64. Amir Eitan; Ocaña Alberto; Šeruga Boštjan; Freedman Orit; Clemons Mark
    Lapatinib and HER2 status: results of a meta-analysis of randomized phase III trials in metastatic breast cancer
    2010
  65. Hevir Neli; Šinkovec Jasna; Lanišnik-Rižner Tea
    Disturbed expression of phase I and II oestrogen-metabolizing enzymes in endometrial cancer
    2010
  66. Pirker Robert; Zakotnik Branko; Zwitter Matjaž
    Therapy of small cell lung cancer with emphasis on oral topotecan
    2010
  67. Šeruga Boštjan; Amir Eitan
    Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis
    2010
  68. Borštnar Simona; Sadikov Aleksander; Možina Barbara; Čufer Tanja
    High levels of uPA and PAI-1 predict a good response to anthracyclines
    2010
  69. Kenig S; Majdič T; Duran-Alonso MB; Lah T
    Endothelial cells increase invasiveness of glioblastoma cells and protect them from apoptosis
    2010
  70. Španinger K; Matos E; Možina B; Borštnar S; Sytkowski AJ; Komel R; Debeljak N
    Isoelectric focusing: method for detection of total erythropoietin in urine and plasma in cancer patients
    2010
  71. Chuang Shu-Chun; Pompe-Kirn Vera
    Risk of second primary cancer among patients with major histological types of lung cancers in both men and women
    2005
  72. Sant Milena; Primic-Žakelj Maja
    EUROCARE-4, survival of cancer patients diagnosed in 1995-1999: results and commentary
    2009
  73. Sant Milena; Primic-Žakelj Maja
    Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study
    2007
  74. Gondos A.; Primic-Žakelj Maja
    Recent trends in cancer survival across Europe between 2000 and 2004: #a #model-based period analysis from 12 cancer registries
    2008
  75. Robins G.; Primic-Žakelj Maja; Potočnik Marjeta
    International variation in Helicobacter pylori infection and rates of oesophageal cancer
    2008
  76. Bouvier Anne-Marie; Pompe-Kirn Vera
    What reasons lie behind long-term survival differences for gastric cancer within Europe?
    2010
  77. Lepage Côme; Pompe-Kirn Vera; Primic-Žakelj Maja
    European disparities in malignant digestive endocrine tumours survival
    2010
  78. De Angelis Roberta; Primic-Žakelj Maja
    The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis
    2009
  79. Berrino Franco; Primic-Žakelj Maja
    Comparative cancer survival information in Europe
    2009
  80. Quaglia Alberto; Primic-Žakelj Maja
    The cancer survival gap between elderly and middle-aged patients in Europe is widening
    2009
  81. Gatta Gemma; Primic-Žakelj Maja
    Survival of European children and young adults with cancer diagnosed 1995-2002
    2009
  82. Anttila Ahti; Primic-Žakelj Maja; Pogačnik Ana; Uršič-Vrščaj Marjetka; Zadnik Vesna
    Description of the national situation of cervical cancer screening in the member states of the European Union
    2009
  83. Rosso Stefano; Primic-Žakelj Maja
    Multiple tumours in survival estimates
    2009
  84. Francisci Silvia; Primic-Žakelj Maja
    The cure of cancer: a European perspective
    2009
  85. Verdecchia Arduino; Primic-Žakelj Maja
    Survival trends in European cancer patients diagnosed from 1988 to 1999
    2009
  86. Brenner Hermann; Primic-Žakelj Maja
    Long-term survival expectations of cancer patients in Europe in 2000-2002
    2009
  87. Micheli Andrea; Primic-Žakelj Maja
    The advantage of women in cancer survival: an analysis of EUROCARE-4 data
    2009
  88. Ravnik M; Snoj N; Sadikov A; Nussdorfer P; Čufer T
    Comparison of adjuvant! Online prediction with 10-year follow-up results according to the uPA and PAI-1 levels in Slovenian early breast cancer patients
    2010
  89. Jančar N; Vrtačnik-Bokal E; Šinkovec J; Kocjan BJ; Poljak M
    Distribution of HPV genotypes in women with cervical cancer in Slovenia and genomic variants of HPV 16, HPV 18 and HPV 33
    2010
  90. Perhavec Andrež; Pohar-Perme Maja; Hočevar Marko; Bešić Nikola; Žgajnar Janez
    Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node
    2010
  91. Maule Milena M.; Pompe-Kirn Vera
    Risk of second malignant neoplasms after childhood central nervous system malignant tumours: #an #international study
    2008
  92. Glavač D
    Diagnostic importance of methylation detection in colorectal cancer
    2009
  93. Glavač Damjan
    Molecular diagnostics of multiple endocrine neoplasia type 2 (MEN II)
    2009
  94. Ravnik-Glavač Metka; Glavač Damjan
    Molecular genetic approaches for screening of patients with hereditary non-poliposis colorectal cancer and genetic counseling
    2009
  95. Glavač Damjan; Potočnik Uroš; Ravnik-Glavač Metka
    New genes mutated within coding mononucleotide repeats in colorectal tumors with high microsatellite instability (Msi)
    2009
  96. Rokavec Matjaž; Schroth Werner; Amaral Sandra M; Fritz Peter; Antoniadou Lydia; Glavač Damjan; Simon Wolfang; Schwab Matthias; Eichelbaum Michel; Brauch Hiltrud
    A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer
    2008
  97. Berginc Gašper; Bračko Matej; Glavač Damjan
    MS-MLPA reveals progressive age-dependent promoter methylation of tumor suppressor genes and possible role of IGSF4 gene in colorectal carcinogenesis of microsatellite instable tumors
    2010
  98. Barzon Luisa; Trevisan Marta; Matkovič Urška; Pacenti Monia; Palu Giorgio
    Role of oncogenic viruses in the pathogenesis of adrenal tumors
    2008
  99. Pacenti M; Matkovič U; Barzon L; Palu G
    Evaluation of adenovirus infection and toxicity in human adrenocortical cells
    2006
  100. Serša Gregor
    Electrochemotherapy in treatment of cutaneous tumors
    2010

1 101 201 301 401 501 601 701 801  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics